Top 5 Drugs Advertising in Professional Health Journals through February 2016

Harvoni

Print advertising dollars in professional health journals reached over $93 million through February 2016, a 5.6% increase year-over-year, according to Kantar Media.

Of the top ten products being advertised in professional health journals through February 2016, only five were on the list at this time in 2015.

Top 5 Print Ad Drugs (Dollars): YTD February 2016
  1. Harvoni Tablets – $3.02 MM (+266.6%)
  2. Trulicity – $1.68 MM (-15.1%)
  3. Viberzi Tablets – $1.65 MM (NA)
  4. Latuda – $1.35 MM (+136.1%)
  5. Xarelto Tablets – $1.01 MM (-9.1%)

The percentage changes compare January-February 2015 to January-February 2016. For more information on these ad insights or other data, let us know.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in professional healthcare. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.





Search article